Testosterone Replacement Therapy: A Clinical Deep Dive

Testosterone is the primary male sex hormone, responsible for far more than just libido and muscle mass. It is a foundational hormone that regulates bone density, red blood cell production, fat distribution, mood, and cognitive function. While testosterone levels naturally decline by about 1% per year after the age of 30, some men experience premature, significant drops in testosterone — a condition known as hypogonadism.

The symptoms of clinically low testosterone are pervasive and often misdiagnosed as depression or simply "getting older." They include profound fatigue, loss of muscle mass, increased visceral fat, brain fog, irritability, and erectile dysfunction. For men with clinically confirmed hypogonadism, Testosterone Replacement Therapy (TRT) is a prescription-only medical treatment that must be initiated and monitored by a registered clinician.

The Diagnostic Process: Beyond Total Testosterone

Diagnosing hypogonadism requires a nuanced approach to blood testing. A single "Total Testosterone" reading is often insufficient. A comprehensive male hormone panel should include:

• Total Testosterone: The total amount of the hormone in the blood. However, the majority of this is bound to proteins and unavailable for the body to use.
• SHBG (Sex Hormone Binding Globulin): A protein produced by the liver that binds tightly to testosterone. If SHBG is high, it traps the testosterone, rendering it inactive.
• Free Testosterone: The unbound, active portion of testosterone that can actually enter cells and exert an effect. This is the most critical marker for diagnosing hypogonadism. A man can have "normal" Total Testosterone but clinically low Free Testosterone due to high SHBG.
• Oestradiol (Estrogen): Men need some estrogen for bone and brain health, but excess body fat can cause an enzyme (aromatase) to convert testosterone into estrogen, leading to mood swings and gynecomastia.
• LH and FSH: Hormones produced by the pituitary gland that signal the testes to produce testosterone. Testing these helps determine if the issue is in the brain (secondary hypogonadism) or the testes (primary hypogonadism).

According to the British Society for Sexual Medicine (BSSM) guidelines, a diagnosis of hypogonadism requires at least two separate early-morning blood samples showing low testosterone, combined with clinical symptoms. TRT should never be prescribed on the basis of a single blood test.

When TRT Is Considered

TRT is a prescription-only medical treatment. It is not a lifestyle supplement or performance enhancer. BSSM and Endocrine Society guidelines recommend TRT only for men with:

• Clinically confirmed hypogonadism on two separate morning blood tests.
• Clear clinical symptoms of testosterone deficiency that significantly impact quality of life.
• Exclusion of reversible causes first: Obesity, poor sleep, chronic stress, type 2 diabetes, and opioid use can all cause secondary hypogonadism. Addressing these underlying issues should always be attempted before starting lifelong hormone therapy.

Risks and Mandatory Monitoring

TRT is a serious medical intervention and requires rigorous ongoing clinical monitoring to ensure safety. The primary risks that must be managed by your prescriber include:

• Erythrocytosis (Thickened Blood): Testosterone stimulates the production of red blood cells. If haematocrit rises too high, it increases the risk of thrombosis and cardiovascular events. Regular full blood count monitoring is essential, and dose adjustments or therapeutic blood donation may be required.
• Prostate Health: TRT does not cause prostate cancer, but it can accelerate the growth of an existing, undiagnosed prostate cancer. Baseline PSA and regular monitoring are mandatory before and during treatment.
• Fertility Suppression: Exogenous testosterone suppresses the brain's production of LH and FSH, which shuts down natural sperm production. TRT can cause temporary or permanent infertility. Men wishing to preserve fertility should discuss options with a specialist before starting treatment.
• Cardiovascular Considerations: The long-term cardiovascular safety of TRT remains an area of active clinical research. Your prescriber will assess your cardiovascular risk profile before initiating therapy.

The Importance of Baseline Testing

Whether you are considering TRT or already on it, comprehensive blood testing is the foundation of safe, effective treatment. A baseline panel provides the objective data your prescriber needs to diagnose hypogonadism accurately and establishes the reference point for all future monitoring.

Important: TRT must only be prescribed and monitored by a registered clinician. Self-administered testosterone obtained from unregulated sources carries serious health risks, including heart attack, stroke, liver damage, and permanent infertility. If you believe you may have low testosterone, speak to your GP or a specialist.

Medical References

1. Bhasin, S., et al. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744.
2. British Society for Sexual Medicine (BSSM). (2023). Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice.
3. Morgentaler, A., et al. (2015). Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clinic Proceedings, 90(7), 884-906.